STK11 and neoplasm: Recent findings extend this regulatory reach to the tumor microenvironment, where LKB1 loss has been shown to modulate immune cell infiltration, inflammatory cytokine production, and stromal remodeling—all pivotal factors in tumor progression and therapeutic resistance (Gao et al., 2010; Koyama et al., 2016; Nguyen and Spranger, 2020).